BTX - Brooklyn ImmunoTherapeutics stock rises ~7% on setting up of new R&D facility

Brooklyn ImmunoTherapeutics (NASDAQ:BTX) said it has set up a new corporate and research and development facility at The Boardwalk at Science Center Drive in San Diego, California to support translational R&D for cell therapies and genetic medicines. “The opening of our state-of-the-art, 5,200 square foot facility represents a significant achievement for Brooklyn as we look to expand upon our research and development efforts over the next two years,” said Brooklyn's President and CEO Howard Federoff. BTX +6.67% to $1.44 premarket April 21

For further details see:

Brooklyn ImmunoTherapeutics stock rises ~7% on setting up of new R&D facility